Syrma SGS Technology Ltd

- Currently, no concrete proposals for inorganic expansion or fundraising through equity or debt have been disclosed. - The company is expanding organically with planned capex of around INR100 crores for a new facility in Pune and INR35-40 crores for a facility in Stuttgart, Germany. - Working capital loan has increased from INR489 crores to INR529 crores, primarily for business-related requirements. - The management is focused on working capital efficiency and reducing working capital days, targeting around 60 days net working capital cycle. - No factoring or bill discounting is being utilized currently, and there are no off-balance sheet receivables. - The company emphasizes building future-ready infrastructure and leadership but has not indicated any imminent plans for fundraising via debt or equity.

- Planned capex for the year is around INR100 crores for a new under-commissioning facility in Pune, expected to start trial production from Q3. - Additional INR35-40 crores allocated for a new facility in Stuttgart, Germany, serving as a prototype and assembly center, also enabling expansion into repair services. - Total capex spent in Q1 was INR70-75 crores, with another INR50-70 crores expected to be spent during the financial year. - Capital allocation focuses primarily on building plant and manufacturing capability both in Pune and Stuttgart. - Inorganic expansion is being evaluated, but currently no concrete proposals or investments are on the table. - Setting up of a subsidiary for adjacent category expansion (OSET) is under careful review, no capital allocation finalized yet.

- **FY25 Revenue Growth Guidance:** 45%-50% growth over previous year's INR3,000 crores target, aiming for around INR4,500 crores. - **Quarterly Growth:** Focus on annualized growth; quarter-on-quarter revenue could be around INR1,000 to INR1,200 crores. - **Order Intake:** Strong and increasing, with INR1,200 crores received in Q1 and a healthy pipeline expected to grow further. - **Exports:** Expected to grow 20%-25% annually, targeting INR1,000+ crores (up from INR800 crores last year), with ramp-up from Q2 onwards. - **Segments:** Consumer business forecasted to be about 40% of sales for the full year, with automotive expected to increase to 20%-25% from 16% in Q1. - **Healthcare and Industrial:** Expected to increase, partially offsetting softer consumer revenue in subsequent quarters. - **Long-term Objective:** Sustainable growth with consumer around 40%, non-consumer 60%, and exports eventually comprising one-third of revenue.

- Syrma SGS aims for 40%-45% revenue growth in FY25 compared to FY24, targeting around INR4,500 crores in annual revenue. - Operating EBITDA guidance is around INR310-325 crores for the full year, translating into sustainable margins of approximately 7% going forward. - Management confident of achieving 7%+ operating EBITDA margins in the second half of FY25, supported by operational efficiencies and product mix normalization. - Exports expected to grow 20%-25% annually, increasing their revenue share from 16% in Q1 FY25 to around 22%-25% for the full year. - Consumer business margins remain low (sub-4%), but higher-margin segments like automotive, industrial, and healthcare will drive margin expansion. - Positive operating cash flows expected as exports and ODM scale up; focus on reducing working capital cycle to around 60 days enhances cash flow. - Investments in Pune and Stuttgart facilities to support growth and operational capability, positioning Syrma for industry-plus growth trajectory.

- Current order book as of June end stands at approximately INR 4,500 crores. - Segment-wise order book breakup: - Auto segment: 23%-25% - Consumer segment: 38%-40% - Industrial segment: 22%-25% - Healthcare: 6%-7% - Remaining from IT and railways. - Order intake for the quarter was about INR 1,200 crores. - Quarterly order intake has been increasing (INR 800 crores in Q4 FY24; approx. INR 1,200 crores in Q1 FY25). - Order intake mainly from auto, industrial, and consumer segments. - The company expects the order pipeline to continue growing. - New customers and order wins in smart metering and medical sectors noted. - Anticipated consistent or increasing order inflow on a quarterly basis going forward.